AmerisourceBergen
AmerisourceBergen was founded in 2001 and is headquartered in Chesterbrook, US
Report incorrect company information
Key People/Management at AmerisourceBergen
Steven Collis
Chairman, President and Chief Executive Officer
Kathy Gaddes
Executive Vice President and Chief Human Resources Officer
Albert Morales
Chief Transformation Officer
Tim Guttman
Executive Vice President and Chief Financial Officer
John Chou
Executive Vice President and Chief Legal & Business Officer
Gina Clark
Executive Vice President and Chief Communications & Administration Officer
Report incorrect company information
AmerisourceBergen Office Locations
AmerisourceBergen has an office in Chesterbrook
Chesterbrook, US (HQ)
1300 Morris Dr
Report incorrect company information
AmerisourceBergen Financials and Metrics
AmerisourceBergen Financials
AmerisourceBergen's revenue was reported to be $153.14 t in FY, 2017
| USD | |
|---|---|
Revenue (Q2, 2018) | 81.5 b |
Gross profit (Q2, 2018) | 2.4 b |
Gross profit margin (Q2, 2018), % | 2.9% |
Net income (Q2, 2018) | 1.1 b |
EBIT (Q2, 2018) | 900.4 m |
Market capitalization (14-Jun-2018) | 20.5 b |
Closing share price (14-Jun-2018) | 93.4 |
Cash (31-Mar-2018) | 2.1 b |
EV | 22.7 b |
AmerisourceBergen's current market capitalization is $20.5 b.
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.2 b | 28.5 b | 30.3 b | 33.6 b | 32.7 b | 34.2 b | 36.7 b | 35.7 b | 36.9 b | 38.2 b | 37.1 b | 38.7 b | 81.5 b |
Cost of goods sold | 28.5 b | 27.7 b | 29.7 b | 32.8 b | 31.8 b | 33.3 b | 35.7 b | 34.6 b | 35.8 b | 37.1 b | 35.9 b | 37.6 b | 79.1 b |
Gross profit | 688.2 m | 729.6 m | 692 m | 752.3 m | 912 m | 891.5 m | 964.9 m | 1.1 b | 1.1 b | 1 b | 1.3 b | 1.1 b | 2.4 b |
Gross profit Margin, % | 2% | 3% | 2% | 2% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 3% |
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 347.5 m | 696.7 m | 1.3 b | 2.3 b | 2.3 b | 2.6 b | 978.1 m | 2.5 b | 1.9 b | 1.8 b | 2.4 b | 1.3 b | 2.1 b |
Current Assets | 15.2 b | 15.8 b | 15.9 b | 20.1 b | 19.6 b | 19.9 b | 20.4 b | 22.1 b | 21.5 b | 23.1 b | 23.5 b | 23.7 b | 26.4 b |
PP&E | 824.1 m | 850.8 m | 882.2 m | 907 m | 955.6 m | 958.7 m | 1.1 b | 1.1 b | 1.2 b | 1.6 b | 1.7 b | 1.7 b | 1.9 b |
Goodwill | 6 b | 6 b | 6 b | 6.7 b |
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 41.4 m | 221.5 m | 208.7 m | (199.9 m) | (713.3 m) | (499.2 m) | 330.4 m | 934.5 m | 1.3 b | 247.2 m | 658.7 m | 709.1 m | 1.1 b |
Accounts Payable | 247.8 m | 351 m | 877 m | 384.4 m | |||||||||
Cash From Operating Activities | (1 b) | 112.7 m | 632.5 m | 897 m | 1.6 b | 2.8 b | 750.8 m | 1.6 b | 1.8 b | (430.4 m) | 368.4 m | 123.7 m | (77.2 m) |
Cash From Investing Activities | (68.2 m) | (128.1 m) | (319.2 m) | (77.2 m) | (2.7 b) | (2.7 b) | (2.8 b) | (2.9 b) | (3 b) | (156.9 m) | (269.5 m) | (406.6 m) | (935.4 m) |
| USD | Y, 2018 |
|---|---|
EV/EBIT | 25.2 x |
EV/CFO | -293.9 x |
EV/FCF | -92.3 x |
Financial Leverage | 11.4 x |
AmerisourceBergen Operating Metrics
| FY, 2016 | |
|---|---|
Countries | 50 |
Distribution Centers | 26 |
AmerisourceBergen Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| MWI Veterinary Supply | January 12, 2015 | $2.50 b |
| TheraCom | December 31, 2011 | $250 m |
| IntrinsiQ | September 06, 2011 | $35 m |
AmerisourceBergen Revenue Breakdown
AmerisourceBergen revenue breakdown by business segment: 95.7% from Pharmaceutical Distribution and 4.3% from Other
Report incorrect company information
AmerisourceBergen Online and Social Media Presence
Report incorrect company information
AmerisourceBergen News and Updates
May 08, 2018
Hill panel probing opioids abuse targets distributor firms
Congress wants wholesale pharmaceutical distributors to explain why so many pills were sent to drug-ravaged West Virginia
March 26, 2018
Biopharmaceutical Logistics Market: Growing Demand for Targeted Therapies to Create Exciting Opportunities
Biopharmaceutical Logistics Market categorizes the global market by Type (Cold Chain Logistics and Non-cold Chain Logistics), Mode of Transportation (Air, Sea, Road, and Rail Shipping), Service & Geography Posted via Industry Today. Follow us on Twitter @IndustryToday
March 08, 2018
Judge charts course to trial for opioid litigation as settlement talks hit barriers
Drugmakers haven't been able to reach a settlement with the hundreds of cities and counties suing them over the opioid epidemic, so a judge is planning early court trials that could point the way to a deal.
March 06, 2018
Lawsuit In Small Town Louisiana Could Pose Major Threat To Opioid Manufacturers
The suit could potentially overshadow a far bigger federal case.
Report incorrect company information